About the journal
Cancer Treatment and Research Communications is an open-access journal published by Elsevier in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 2,940 USD. Declared review time at DOAJ: 20 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2468-2942
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,940 USD
- Articles in DOAJ
- 1137
- Declared review time
- 20 weeks
- Declared peer-review model
- peer_review
Index listings
- DOAJ · 2021-12-01
- MEDLINE · 2018-01-01
- PUBMED · 2023-10-20
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 2,940 USD
- Declared review time (DOAJ)
- 20 weeks
- Actual review time (measured)
- 122 days received→accepted — computed from PubMed (n=98)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
1137
Most recent article
last month
Average review time (journal-declared via DOAJ)
20weeks
Works in OpenAlex
1232
Last recorded publication year
2026
h-index
37
i10-index
289
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2021-12-01
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 98%
- ORCID iDs in current deposits
- 72%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101694651
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Lung Cancer Research Studies
Show all subjects (50)
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Global Cancer Incidence and Screening
- HER2/EGFR in Cancer Research
- Global Cancer Incidence and Screening
- Colorectal Cancer Treatments and Studies
- Ferroptosis and cancer prognosis
- Breast Lesions and Carcinomas
- Breast Lesions and Carcinomas
- Ferroptosis and cancer prognosis
- Prostate Cancer Treatment and Research
- Bladder and Urothelial Cancer Treatments
- Prostate Cancer Treatment and Research
- Cancer Treatment and Pharmacology
- Advanced Breast Cancer Therapies
- Head and Neck Cancer Studies
- Bladder and Urothelial Cancer Treatments
- Advanced Breast Cancer Therapies
- Cancer Treatment and Pharmacology
- Radiomics and Machine Learning in Medical Imaging
- Endometrial and Cervical Cancer Treatments
- Prostate Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment
- Head and Neck Cancer Studies
- Cancer Risks and Factors
- Renal cell carcinoma treatment
- Cancer Risks and Factors
- Prostate Cancer Diagnosis and Treatment
- Endometrial and Cervical Cancer Treatments
- Radiomics and Machine Learning in Medical Imaging
- Pancreatic and Hepatic Oncology Research
- Lymphoma Diagnosis and Treatment
- Inflammatory Biomarkers in Disease Prognosis
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Pancreatic and Hepatic Oncology Research
- Lymphoma Diagnosis and Treatment
- Inflammatory Biomarkers in Disease Prognosis
Keywords (DOAJ)
- cancer research
- oncology
- cancer diagnosis and treatment
- molecular oncology
- clinical trials in oncology
- cancer prevention
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ